[1]
“Formulation and in-vitro bioequivalence evaluation of verapamil hydrochloride matrix tablets with Calan R”, Int Curr Pharm J, vol. 3, no. 6, pp. 286–290, May 2014, doi: 10.3329/icpj.v3i6.18761.